Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Livermore

Showing results (71-80 of 269) with videos related to

Pageof 27
Sort By:
The Journal of Antimicrobial Chemotherapy|October 10, 2008
Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001-06David M Livermore, Russell Hope, Geraldine Brick, et al.
The Journal of Antimicrobial Chemotherapy|March 2, 2013
Activity of BAL30072 alone or combined with β-lactamase inhibitors or with meropenem against carbapenem-resistant Enterobacteriaceae and non-fermentersShazad Mushtaq, Neil Woodford, Russell Hope, et al.
The Journal of Antimicrobial Chemotherapy|August 12, 2008
NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum beta-lactamases and carbapenemasesDavid M Livermore, Shazad Mushtaq, Marina Warner, et al.
The Journal of Antimicrobial Chemotherapy|August 31, 2015
Susceptibility testing challenges with ceftaroline, MRSA and a 1 mg/L breakpointDavid M Livermore, Shazad Mushtaq, Marina Warner, et al.
Antimicrobial Agents and Chemotherapy|September 22, 2020
<i>In Vitro</i> Activity of Cefiderocol, a Siderophore Cephalosporin, against Multidrug-Resistant Gram-Negative BacteriaShazad Mushtaq, Zahra Sadouki, Anna Vickers, et al.
The Journal of Antimicrobial Chemotherapy|March 15, 2006
Effect of subinhibitory concentrations of antibiotics on mutation frequency in Streptococcus pneumoniaeStephanie K Henderson-Begg, David M Livermore, Lucinda M C Hall
Antimicrobial Agents and Chemotherapy|June 20, 2018
Activity of RX-04 Pyrrolocytosine Protein Synthesis Inhibitors against Multidrug-Resistant Gram-Negative BacteriaAnna Vickers, Shazad Mushtaq, Neil Woodford, et al.
The Journal of Antimicrobial Chemotherapy|April 3, 2022
Inoculum effects of cefepime/zidebactam (WCK 5222) and ertapenem/zidebactam (WCK 6777) for Enterobacterales in relation to β-lactamase type and enhancer effect, as tested by BSAC agar dilutionShazad Mushtaq, Anna Vickers, Aiysha Chaudhry, et al.
The Journal of Antimicrobial Chemotherapy|August 8, 2018
Doxycycline in UK guidelines for hospital-acquired pneumonia: where is the evidence base?Alicia H Russell, Carolyne Horner, David M Livermore, et al.
The Journal of Antimicrobial Chemotherapy|January 11, 2008
Linkage of acquired quinolone resistance (qnrS1) and metallo-beta-lactamase (blaVIM-1) genes in multiple species of Enterobacteriaceae from Bolzano, ItalyRichard Aschbacher, Michel Doumith, David M Livermore, et al.
Pageof 27

Showing results (71-80 of 269) with videos related to

Sort By:
Pageof 27
The Journal of Antimicrobial Chemotherapy|October 10, 2008
Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001-06David M Livermore, Russell Hope, Geraldine Brick, et al.
The Journal of Antimicrobial Chemotherapy|March 2, 2013
Activity of BAL30072 alone or combined with β-lactamase inhibitors or with meropenem against carbapenem-resistant Enterobacteriaceae and non-fermentersShazad Mushtaq, Neil Woodford, Russell Hope, et al.
The Journal of Antimicrobial Chemotherapy|August 12, 2008
NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum beta-lactamases and carbapenemasesDavid M Livermore, Shazad Mushtaq, Marina Warner, et al.
The Journal of Antimicrobial Chemotherapy|August 31, 2015
Susceptibility testing challenges with ceftaroline, MRSA and a 1 mg/L breakpointDavid M Livermore, Shazad Mushtaq, Marina Warner, et al.
Antimicrobial Agents and Chemotherapy|September 22, 2020
<i>In Vitro</i> Activity of Cefiderocol, a Siderophore Cephalosporin, against Multidrug-Resistant Gram-Negative BacteriaShazad Mushtaq, Zahra Sadouki, Anna Vickers, et al.
The Journal of Antimicrobial Chemotherapy|March 15, 2006
Effect of subinhibitory concentrations of antibiotics on mutation frequency in Streptococcus pneumoniaeStephanie K Henderson-Begg, David M Livermore, Lucinda M C Hall
Antimicrobial Agents and Chemotherapy|June 20, 2018
Activity of RX-04 Pyrrolocytosine Protein Synthesis Inhibitors against Multidrug-Resistant Gram-Negative BacteriaAnna Vickers, Shazad Mushtaq, Neil Woodford, et al.
The Journal of Antimicrobial Chemotherapy|April 3, 2022
Inoculum effects of cefepime/zidebactam (WCK 5222) and ertapenem/zidebactam (WCK 6777) for Enterobacterales in relation to β-lactamase type and enhancer effect, as tested by BSAC agar dilutionShazad Mushtaq, Anna Vickers, Aiysha Chaudhry, et al.
The Journal of Antimicrobial Chemotherapy|August 8, 2018
Doxycycline in UK guidelines for hospital-acquired pneumonia: where is the evidence base?Alicia H Russell, Carolyne Horner, David M Livermore, et al.
The Journal of Antimicrobial Chemotherapy|January 11, 2008
Linkage of acquired quinolone resistance (qnrS1) and metallo-beta-lactamase (blaVIM-1) genes in multiple species of Enterobacteriaceae from Bolzano, ItalyRichard Aschbacher, Michel Doumith, David M Livermore, et al.
Pageof 27